Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, offering promising developments across many healthcare and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA gives a safer, much more trustworthy different for therapeutic use, especially